LaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor
LaunchBio’s signature rare disease forum, returns on February 12, 2026, bringing together investors, foundations, and early-stage biotech companies at UCSF
Artificial intelligence is transforming how new therapies are discovered, developed, and delivered, but for early-stage biotech companies, that transformation comes...
Artificial intelligence is transforming how new therapies are discovered, developed, and delivered, but for early-stage biotech companies, that transformation comes...